Sandra Calvin - 04 Nov 2025 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
SVP, CHIEF ACCOUNTING OFFICER
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Issuer symbol
TVTX
Transactions as of
04 Nov 2025
Net transactions value
-$944,928
Form type
4
Filing time
06 Nov 2025, 16:05:05 UTC
Previous filing
12 Feb 2025
Next filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER C/O TRAVERE THERAPEUTICS, INC., 3611 VALLEY CENTRE DRIVE, SUITE 300, SAN DIEGO /s/ Elizabeth E. Reed, Attorney-in-Fact 05 Nov 2025 0001882909

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Options Exercise $252,500 +10,000 +18% $25.25 64,410 04 Nov 2025 Direct
transaction TVTX Common Stock Options Exercise $470,400 +17,500 +27% $26.88 81,910 04 Nov 2025 Direct
transaction TVTX Common Stock Options Exercise $412,500 +15,000 +18% $27.50 96,910 04 Nov 2025 Direct
transaction TVTX Common Stock Options Exercise $280,000 +12,500 +13% $22.40 109,410 04 Nov 2025 Direct
transaction TVTX Common Stock Options Exercise $55,812 +6,250 +5.7% $8.93 115,660 04 Nov 2025 Direct
transaction TVTX Common Stock Sale $2,416,140 -67,115 -58% $36.00 48,545 04 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TVTX Employee stock option (right to buy) Options Exercise $0 -10,000 -100% $0.000000 0 04 Nov 2025 Common Stock 10,000 $25.25 Direct F2
transaction TVTX Employee stock option (right to buy) Options Exercise $0 -17,500 -100% $0.000000 0 04 Nov 2025 Common Stock 17,500 $26.88 Direct F2
transaction TVTX Employee stock option (right to buy) Options Exercise $0 -15,000 -86% $0.000000 2,500 04 Nov 2025 Common Stock 15,000 $27.50 Direct F3
transaction TVTX Employee stock option (right to buy) Options Exercise $0 -12,500 -62% $0.000000 7,500 04 Nov 2025 Common Stock 12,500 $22.40 Direct F4
transaction TVTX Employee stock option (right to buy) Options Exercise $0 -6,250 -25% $0.000000 18,750 04 Nov 2025 Common Stock 6,250 $8.93 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was made pursuant to a written plan adopted on June 10, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
F2 The stock option is fully vested and exercisable.
F3 One-fourth of the shares subject to the stock option vested and became exercisable on the first anniversary of January 31, 2022, and the remaining shares vest in 36 equal monthly installments thereafter.
F4 One-fourth of the shares subject to the stock option vested and became exercisable on the first anniversary of January 31, 2023, and the remaining shares vest in 36 equal monthly installments thereafter.
F5 One-fourth of the shares subject to the stock option vested and became exercisable on the first anniversary of January 31, 2024, and the remaining shares vest in 36 equal monthly installments thereafter.